Goldman Sachs Group Inc Eucrates Biomedical Acquisition Corp. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
SELL
$9.89 - $10.0 $247,250 - $250,000
-25,000 Reduced 44.95%
30,622 $307,000
Q3 2022

Nov 10, 2022
SELL
$9.89 - $10.0 $247,250 - $250,000
-25,000 Reduced 44.95%
30,622 $0
Q2 2022

May 14, 2024
BUY
$9.85 - $9.91 $547,876 - $551,214
55,622 New
55,622 $550,000
Q2 2022

Aug 15, 2022
SELL
$9.85 - $9.91 $4.91 Million - $4.94 Million
-498,000 Reduced 89.95%
55,622 $550,000
Q1 2022

May 16, 2022
BUY
$9.76 - $9.85 $5.06 Million - $5.11 Million
518,510 Added 1476.73%
553,622 $5.45 Million
Q4 2021

Feb 14, 2022
SELL
$9.75 - $9.85 $20,377 - $20,586
-2,090 Reduced 5.62%
35,112 $343,000
Q3 2021

Nov 10, 2021
BUY
$9.65 - $9.99 $358,999 - $371,647
37,202 New
37,202 $364,000

About Eucrates Biomedical Acquisition Corp.

EUCR Quotes by TradingView
  • Ticker EUCR
  • Exchange
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,459,100
More about EUCR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email